SECsense Logo

Inspira Technologies 6-K Report: New Collaboration with Zriha Medical Unveiled!

$IINN
Form 6-K
Filed on: 2025-01-17
Source
Inspira Technologies 6-K Report: New Collaboration with Zriha Medical Unveiled!

Here are the key insights extracted from the provided financial report (6-K) of Inspira Technologies Oxy B.H.N. Ltd.:

  1. Filing Type and Date:
  • This is a Form 6-K report filed on January 17, 2025, which is used by foreign private issuers to report information that is material to investors.
  1. Company Information:
  • Name: Inspira Technologies Oxy B.H.N. Ltd.
  • Commission File Number: 001-40303.
  • Address: 2 Ha-Tidhar St., Ra'anana 4366504, Israel.
  1. Press Release Announcement:
  • The report includes a press release dated January 17, 2025, titled “Inspira™ Technologies Collaborates With Zriha Medical To Launch Cutting-Edge Production Line.”
  • This collaboration suggests a strategic partnership likely aimed at enhancing production capabilities or technological advancements in their field.
  1. Registration Statements:
  • The press release is incorporated by reference into the company's existing Registration Statements on Form F-3 and Form S-8, indicating ongoing compliance with SEC regulations regarding securities registration.
  1. Signatory Information:
  • The report is signed by Dagi Ben-Noon, the Chief Executive Officer of Inspira Technologies, which adds credibility to the disclosures made in the report.
  1. Regulatory Compliance:
  • The filing complies with the requirements of the Securities Exchange Act of 1934, which regulates the public reporting obligations of companies.

This report highlights a significant development in the company's operations through a new collaboration, suggesting potential growth and innovation in their production capabilities. The incorporation of the press release into official SEC documents also reflects a commitment to transparency and regulatory compliance.